Physician profile
Corbin Grubbs
NPI 1205522190
$264.17
in general payments reported to CMS, 2019-2025
9 companies · $60.22 in 2025
The $60.22 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $136 · 2024: $68.29 · 2025: $60.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.88 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $41.87 | 2023-2024 | Verquvo, Zerbaxa, Dificid |
| Pfizer INC. | $38.33 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $34.83 | 2024 | Xarelto |
| Acorda Therapeutics, INC | $26.80 | 2023 | Inbrija |
| Acadia Pharmaceuticals INC | $22.93 | 2023 | Nuplazid |
| Abbvie INC. | $22.37 | 2023 | |
| Janssen Biotech, INC. | $18.57 | 2025 | Tremfya |
| Vertex Pharmaceuticals Incorporated | $14.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corbin Grubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.